May 30, 2024
Covid Updates Featured Latest News National

Corbevax Approved As Booster Dose For Adults Vaccinated With Covaxin, Covishield

According to official sources, the government has approved Biological E’s Corbevax as a preventative dose or booster shot for adults over 18 who have had both the Covishield and Covaxin vaccines. This is the first time a different booster dose than the one used for the primary Covid immunisation has been authorised in the nation.

According to the sources cited by Press Trust of India, the recent recommendations provided by the COVID-19 Working Group of the National Technical Advisory Group on Immunization served as the foundation for the Union Health Ministry’s acceptance (NTAGI).

“Corbevax will be considered as a precaution dose after completion of six months or 26 weeks from the date of administration of the second dose of either Covaxin or Covishield vaccines for those aged above 18 years enabling use of Corbevax as a heterologous COVID-19 vaccine for precaution dose administration in this age group,” the sources told Press Trust of India.

According to the sources, this will be in addition to the current recommendations for administering homologous prophylactic doses of the Covaxin and Covishield vaccines.

On the Co-WIN portal, all essential adjustments are being made in relation to the delivery of the precautionary dosage of the Corbevax vaccination.

Corbevax, the country’s first RBD protein subunit vaccine, is presently administered to youngsters between the ages of 12 and 14 as part of the COVID-19 immunisation program.

In its meeting on July 20, the COVID-19 Working Group (CWG) reviewed data from the double-blind randomised phase-3 clinical study that assessed the immunogenicity and safety of a booster dose of the Corbevax vaccine when given to adult volunteers aged 18 to 80 who had previously received two doses of either Covishield or Covaxin.

On June 4, the Drugs Controller General of India (DCGI) approved Corbevax as a precautionary dose for individuals 18 years of age and above.

Picture Courtesy: Google/images are subject to copyright

Share

Related Posts

Leave a Reply

Your email address will not be published. Required fields are marked *